title: Ranibizumab: reject such high (exorbitant) prices.
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D000068258:Bevacizumab; D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy; D056687:Off-Label Use; D000069579:Ranibizumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab